Keyphrases
Access Policy
14%
Access to Information
14%
Affordable Access
14%
Biomanufacturing
14%
Biopharmaceutical Development
14%
Biopharmaceutical Manufacturing
14%
Biopharmaceutical Research
14%
Biopharmaceuticals
100%
Canada
100%
Canadian Government
14%
Canadian Public
42%
Clinical Data
14%
Clinical Management
14%
COVID-19
57%
COVID-19 Pandemic
100%
Data Filed
14%
Document-oriented
14%
Financialization
100%
Funding Institutions
14%
Funding Policy
14%
Government Efforts
14%
Government of Canada
28%
Incremental Change
14%
Information Acts
14%
Intellectual Property
14%
Intellectual Property Management
14%
Internet Publics
14%
Long-term Sustainability
14%
Manufacturing Capacity
14%
Medical Countermeasures
100%
Opacity
14%
Pandemic Response
14%
Policy Announcement
14%
Policy Change
14%
Policy Goals
14%
Political Economy
14%
Private Sector Firms
14%
Private Sector Participation
14%
Public Data Repositories
14%
Public Funding
100%
Public Investment
14%
Public Policy
14%
Publicly Funded Research
14%
Research Contracts
14%
Stage Development
14%
Transparent Access
14%
Virus Transmission
14%
Social Sciences
Biologic Agent
100%
Canada
100%
Computer Aided Design
50%
Contract Research
25%
COVID 19 Epidemic
100%
COVID-19
75%
Financialization
100%
Funding Policy
25%
Government Policy
25%
Industrial Sector
25%
Intellectual Property
50%
Private Sector
50%
Public Investment
25%
Research and Development
75%
Therapy
25%
Medicine and Dentistry
Biopharmaceuticals
100%
Clinical Management
25%
COVID-19
100%
Developmental Stage
25%
Diagnosis
25%
Therapeutic Vaccine
25%
Virus Transmission
25%
Biochemistry, Genetics and Molecular Biology
Biomanufacturing
100%
Developmental Stage
100%
Virus Transmission
100%
Agricultural and Biological Sciences
Canadians
100%
Developmental Stage
25%
Public Policy
25%
Research and Development
75%
Economics, Econometrics and Finance